APA

Yang S. J., Choi J. M., Kim L., Kim B., Sohn J. H., Kim W. J., Park S. E., Rhee E. J., Lee W. Y., Oh K. W., Park S. W., Kim S. W. & Park C. (20110531). Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. : Biochemical and biophysical research communications.

Chicago

Yang Soo Jin, Choi Jung Mook, Kim Lisa, Kim Byung-Joon, Sohn Jin Hee, Kim Won Jun, Park Se Eun, Rhee Eun Jung, Lee Won Young, Oh Ki Won, Park Sung Woo, Kim Sun Woo and Park Cheol-Young. 20110531. Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. : Biochemical and biophysical research communications.

Harvard

Yang S. J., Choi J. M., Kim L., Kim B., Sohn J. H., Kim W. J., Park S. E., Rhee E. J., Lee W. Y., Oh K. W., Park S. W., Kim S. W. and Park C. (20110531). Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. : Biochemical and biophysical research communications.

MLA

Yang Soo Jin, Choi Jung Mook, Kim Lisa, Kim Byung-Joon, Sohn Jin Hee, Kim Won Jun, Park Se Eun, Rhee Eun Jung, Lee Won Young, Oh Ki Won, Park Sung Woo, Kim Sun Woo and Park Cheol-Young. Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. : Biochemical and biophysical research communications. 20110531.